Vertex Pharmaceuticals (NASDAQ: VRTX) is a biotechnology company with a strong track record of success in developing ...

Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $416.96, moving -1.72% from the previous trading session.

Analysis of the S&P 500 health care sector's performance, quant ratings of top companies, and expert opinions on future ...

The increasing adoption of e-invoicing globally and the ongoing enterprise resource planning (ERP) migration super cycle present multi-year growth opportunities for Vertex. As companies shift to cloud ...

Vertex is paying Orna $65 million upfront, in part via convertible note, according to a Jan. 7 release. Orna—which acquired ...

Making Artificial Intelligence systems robustly perceive humans remains one of the most intricate challenges in computer ...

During the last century, biologists have extensively studied Drosophila melanogaster, the common household fruit fly. It's ...

(RTTNews) - EPAM Systems, Inc. (EPAM), Wednesday announced an expansion of its partnership with Google Cloud to deliver innovative industry solutions. The collaboration, with the support of Google ...

ClearBridge Investments, an investment management company, released its “ClearBridge Growth Strategy” fourth quarter 2024 ...

EPAM Systems (EPAM) announced it has expanded its strategic partnership with Google Cloud (GOOG, GOOGL)to deliver innovative industry ...

Vertex Pharmaceuticals is an innovative powerhouse with a good stock to buy on the dip. You can look at the momentum for some stocks and have a feeling that it's about to end. Others, though, have ...

Persistent Systems, a global digital engineering firm, today announced the release of Pi-OmniKG, an AI-powered knowledge ...